Results 161 to 170 of about 312,671 (350)
Constipation in Iran: SEPAHAN systematic review No. 5
Background: Constipation is physically and mentally troublesome for many patients and has adverse effects on their quality of life. The aim of the present study was to systematically review previous studies on the epidemiology of constipation in Iran ...
Niloufar Iraji+5 more
doaj
ADHESIONS OF THE SIGMOID ASSOCIATED WITH CONGENITAL ABNORMALITY OF THE MESENTERY CAUSING CONSTIPATION. [PDF]
J. P. Lockhart-Mummery, Drury Pennington
openalex +1 more source
Abstract Belumosudil is an oral selective rho‐associated coiled‐coil containing protein kinase 2 inhibitor, approved as a treatment for chronic graft‐versus‐host disease. Prior clinical studies demonstrated that coadministration with strong CYP3A4 inducers or proton pump inhibitors requires dose modification of belumosudil.
Olivier Schueller+4 more
wiley +1 more source
COLITIS, CONSTIPATION AND APPENDICITIS: THEIR ETILOGIC RELATIONS. [PDF]
MILES F. PORTER
openalex +1 more source
Epidermolysis bullosa for primary care providers: A practical review
Abstract Epidermolysis bullosa (EB) is a group of genetic skin diseases, which manifest as fragile skin and blistering in addition to many extracutaneous conditions. Pediatricians and primary care providers play an integral role in managing these patients with multifaceted care needs.
Kennedy Sparling+9 more
wiley +1 more source
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi+21 more
wiley +1 more source
BackgroundThe association between coffee consumption and constipation remains unclear. This study aimed to examine the relationship of coffee consumption with the risk of constipation, while also investigating potential effect modifiers.MethodsThis cross-
Wanru Kong, Wei Sheng, Ya Zheng
doaj +1 more source
Abstract Background LIBRETTO‐001 is an ongoing, global, open‐label, phase I/II study of selpercatinib in patients with advanced or metastatic solid tumors. We report interim patient‐reported outcomes in patients with RET fusion–positive non‐small cell lung cancer (NSCLC).
Anna Minchom+11 more
wiley +1 more source